+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

SAXENDA Drug Profile, 2019

  • ID: 4727216
  • Report
  • 120 pages
  • thinkBiotech LLC
1 of 4

FEATURED COMPANIES

  • A Wuxi Apptec Company
  • Labnetwork
  • Novo Nordisk
  • MORE
SAXENDA Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on SAXENDA and covers the following critical aspects of this drug:
  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • A Wuxi Apptec Company
  • Labnetwork
  • Novo Nordisk
  • MORE
  • Profile for SAXENDA
  • US Patents
  • Expired US Patents
  • US District Court Litigation
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novo Nordisk
  • Labnetwork
  • A Wuxi Apptec Company
Note: Product cover images may vary from those shown
Adroll
adroll